Vergoeding 2015-2019 voor ATC-subgroep L02AE : Gonadoreline-analogen
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| L02AE01 Busereline (Suprefact ®) | 664.540 | 898.210 | 752.310 | 773.300 | 905.150 |
| L02AE02 Leuproreline (Lucrin pds ®) | 14.299.900 | 14.602.400 | 15.245.300 | 15.711.000 | 15.811.800 |
| L02AE03 Gosereline (Zoladex ®) | 11.075.500 | 11.532.300 | 11.790.800 | 12.178.200 | 13.106.800 |
| L02AE04 Triptoreline (Pamorelin ®) | 1.956.000 | 2.228.500 | 2.406.400 | 3.008.200 | 3.682.500 |
| L02AE05 Histreline | 25.462 | . | . | . | . |
| Totaal | 28.021.402 | 29.261.410 | 30.194.810 | 31.670.700 | 33.506.250 |